Emerging adverse cutaneous drug reactions.

TitleEmerging adverse cutaneous drug reactions.
Publication TypeJournal Article
Year of Publication2012
AuthorsHagen JW, Magro CM, A Crowson N
JournalDermatol Clin
Volume30
Issue4
Pagination695-730, vii
Date Published2012 Oct
ISSN1558-0520
KeywordsAntibodies, Monoclonal, Antigens, CD20, Antineoplastic Agents, Drug Eruptions, Humans, Hydroxyurea, Immunoglobulins, Intravenous, Immunologic Factors, Interferon-alpha, Interleukin-2, Levamisole, Receptors, Tumor Necrosis Factor, Tumor Necrosis Factor-alpha, Vascular Endothelial Growth Factor A
Abstract

The past several decades have seen the advent and rapidly expanding use of biological agents in the treatment of chronic disease states. As increasingly large pools of patients have been enrolled in treatment protocols using these agents, physicians have become acquainted with both desired and adverse events associated with their use. Dermatologists frequently encounter patients affected by cutaneous drug reactions associated with the use of biological agents, thereby becoming familiar with the full range of side effects reported in the literature. This review discusses these adverse cutaneous effects, their underlying mechanisms, and efforts to predict and minimize their occurrence.

DOI10.1016/j.det.2012.06.016
Alternate JournalDermatol Clin
PubMed ID23021055
Related Faculty: 
Cynthia M. Magro, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700